Dotmatics recently launched Dotmatics Luma™, a multimodal R&D platform that transforms laboratory workflows in therapeutic discovery. Its inaugural offering, the Luma Antibody & Protein Engineering solution, is designed to optimize the antibody and protein development process by integrating comprehensive tools for monoclonal and multispecific antibody research. For lab managers, this solution offers powerful features to ensure efficient, collaborative, and versatile laboratory operations.
Key benefits of Dotmatics Luma™ for lab managers
Dotmatics Luma™ is purpose-built to provide lab managers with efficient tools that foster cross-functional collaboration while reducing redundancies in the workflow.
- Integrated Scientific Tools: Combines Geneious®, GraphPad® Prism, OMIQ®, Protein Metrics Byos®, and FCS Express®, creating an all-in-one environment.
- Enhanced Data Cohesion: Reduces data silos, enabling smoother transitions across research phases.
- Supports Multiple Therapeutic Areas: From CAR-T to CRISPR and ADCs, managers can diversify lab capabilities.
- Reduced Workflow Complexities: Simplifies lab workflows, allowing teams to manage data and tasks within a single platform.
- Collaborative Platform: Enhances communication and data sharing among lab teams for better results.
Accelerate multimodal therapeutic research with ease
Dotmatics Luma™ empowers lab managers to facilitate cross-modality research efficiently. By enabling easy access to data and compatible tools, it provides a more cohesive experience that meets the growing demands for therapeutic discovery across various modalities. The Luma Antibody & Protein Engineering solution marks the beginning of a versatile series of tools that will drive lab productivity forward.
This article is an AI generated summary of a published press release provided by Dotmatics
